Utah Medical Products, Inc. Reports Financial Performance For Fourth Quarter And Year 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SALT LAKE CITY, Jan. 30, 2014 (GLOBE NEWSWIRE) -- Utah Medical Products, Inc. (Nasdaq:UTMD) concluded another excellent financial year in 2013 under difficult conditions. The results according to Generally Accepted Accounting Principles in the U.S. (US GAAP) are clouded somewhat by a favorable adjustment to UTMD’s tax provision, as explained below.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC